NCT05985239Completed
Virtual Ileostomy Versus Diverting Ileostomy
Comparing the Safety and Efficacy of Virtual Ileostomy Versus Diverting Ileostomy in Patients Underwent Total Mesorectal Excision for Rectal Cancer: a Propensity-matched Study
Source: ClinicalTrials.gov · Last updated 15 Oct 2024
Brief summary (registry, in English)
This study aimed at comparing the Comprehensive Complication Index (CCI), readmission rates, postoperative hospitalization days, duration of bearing the stoma (months), hospitalization costs, the number of hospitalizations with virtual ileostomy versus conventional divertingileostomy after total mesorectal excision for rectal cancer.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 612 (actual)
- First submitted
- 14 Jul 2023
- Start date
- 1 Jan 2023
- Primary completion date
- 10 Oct 2024
- Lead sponsor
- fan li
- Diseases
- Colorectal cancer
- NCT number
- NCT05985239
What you commit to
- Study type: Observational
- Participants enrolled: 612
- From 1 Jan 2023 to the primary completion date, 10 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Emergency surgery, open surgery
- Combined severe cardiac disease: with congestive heart failure or NYHA cardiac function ≥ grade 2. Patients with a history of myocardial infarction or coronary artery surgery within 6 months before the procedure
- Intraoperative combined multi-organ resection
Other illness
- Long-term history of using immunosuppressants or glucocorticoids
- Chronic renal failure (requiring dialysis or glomerular filtration rate \<30 mL/ min)
Other
- ASA score \>3points
- Patients with combined complete intestinal obstruction
- Combined cirrhosis of the liver
- Intraoperative findings of incomplete anastomosis and positive insufflation test
- missing information
Who the study is looking for
- Diagnosis of rectal cancer confirmed by pathology
- Age ≥ 18 years
- Lap/robot total mesorectal excision (TME) surgical procedures and colon-rectum or colon-anal anastomosis#1.anterior resection (AR/ PME), 2. low anterior resection (LAR) , 3.intersphincteric abdominoperineal resection (ISR), 4.transanal total mesorectal excision (TaTME)
- Ability to understand the nature and risks of participating in the trial
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Daping Hospital, Third Military Medical University Coordinator of this site? Confirm its status | Chongqing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.